Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations
Mitochondrial dysfunction is a common pathological hallmark in various inflammatory and degenerative diseases of the central nervous system, including multiple sclerosis (MS). We previously showed that oxidative stress alters axonal mitochondria, limiting their transport and inducing conformational...
Saved in:
Main Authors: | Bimala Malla (Author), Samuel Cotten (Author), Rebecca Ulshoefer (Author), Friedemann Paul (Author), Anja E. Hauser (Author), Raluca Niesner (Author), Helena Bros (Author), Carmen Infante-Duarte (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An update of teriflunomide for treatment of multiple sclerosis
by: Oh J, et al.
Published: (2013) -
Teriflunomide-induced Palmoplantar Lichenoid Eruption: A Case Report
by: Gökçe Işıl Kurmuş, et al.
Published: (2024) -
Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19
by: Amgad M. Rabie
Published: (2021) -
Peripheral Nerve Regeneration
Published: (2019) -
Medication Adherence and Healthcare Utilization in Relapsing-Remitting Multiple Sclerosis Patients Using Teriflunomide
by: Greene N, et al.
Published: (2022)